Bruton tyrosine kinase inhibitors and cardiovascular adverse events

British Journal of Pharmacology · Published 2026-07-30 · DOI 10.1111/bph.70620

Free full text

Authors (5)

Massimiliano Camilli, Cristina Madaudo, Emanuela Salvatorelli, Giorgio Minotti, Pierantonio Menna

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Camilli, M., Madaudo, C., Salvatorelli, E., et al. (2026). Bruton tyrosine kinase inhibitors and cardiovascular adverse events. British Journal of Pharmacology. https://doi.org/10.1111/bph.70620

Related articles

• Novel BTK inhibitors and degraders for relapsed/refractory CLL/SLL: latest updates from ASH 2025 annual meeting · Journal of Hematology & Oncology · 2026 · Cites or is cited by this article
• Ibrutinib and Bruton’s Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Focus on Atrial Fibrillation and Ventricular Tachyarrhythmias/Sudden Cardiac Death · Chemotherapy · 2022 · Cites or is cited by this article
• EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation · HemaSphere · 2026 · Cites or is cited by this article
• Adjudication of Adverse Cardiovascular Events in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib: Deaths in GLOW or Blowing in the Wind? · European Cardiology Review · 2025 · Cites or is cited by this article
• Activation of sigma non‐opioid intracellular receptor 1 (S1R) receptor inhibits plexin domain containing 2 (Plxdc2) driven microglial inflammation to ameliorate depressive‐like behaviours in mice · British Journal of Pharmacology · 2026 · Same journal
• Acute anaphylactic and multiorgan inflammatory effects of Comirnaty in pigs: evidence of spike protein mRNA transfection and paralleling inflammatory cytokine upregulation · British Journal of Pharmacology · 2026 · Same journal
• A novel quinoline and manganese‐based carbon monoxide‐releasing molecule for intravesical therapy of bladder cancer · British Journal of Pharmacology · 2026 · Same journal
• Serotonin engages divergent 5‐HT receptor pathways for cell type‐resolved modulation of prefrontal layer 5 microcircuits · British Journal of Pharmacology · 2026 · Same journal
• Decoding functional specialization in G protein‐coupled receptors (GPCRs) through evolution‐guided residue profiling · British Journal of Pharmacology · 2026 · Same journal
• Arrhythmias associated with immune checkpoint inhibitor therapy—A clinical perspective · British Journal of Pharmacology · 2026 · Same journal